Constrained Boundary Monitoring for Group Sequential Clinical Trials
Download the Paper Forward to a colleague
Abstract:
Group sequential stopping rules are often used during the conduct of clinical trials in order to attain more ethical treatment of patients and to better address efficiency concerns. Because the use of such stopping rules materially affects the frequentist operating characteristics of the hypothesis test, it is necessary to choose an appropriate stopping rule during the planning of the study. It is often the case, however, that the number and timing of interim analyses are not precisely known at the time of trial design, and thus the implementation of a particular stopping rule must allow for flexible determination of the schedule of interim analyses. In this paper we consider the use of constrained stopping boundaries in the implementation of stopping rules. We compare this approach when used on various scales for the test statistic. When implemented on the scale of boundary crossing probabilities, this approach is identical to the error spending function approach of Lan & DeMets (1983).
Subject Area:
Clinical Trials
Suggested Citation:
Bart E. Burington and Scott S. Emerson, "Constrained Boundary Monitoring for Group Sequential Clinical Trials" (April 25, 2003). UW Biostatistics Working Paper Series. Working Paper 199.
http://www.bepress.com/uwbiostat/paper199
Previous Versions:
Click a date to download that version.
April 25, 2003